Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.86 |
| ▸ | LMNA | P02545 | 3/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.86 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16762811 | 1.00 | ALDH1A1 (0.86) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| SCHEMBL21908164 | 1.00 | ALDH1A1 (0.86) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| SCHEMBL469376 | 1.00 | ALDH1A1 (0.86) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| SCHEMBL10067446 | 0.93 | ALDH1A1 (0.74) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| Octocrylene SCHEMBL16483 | 0.93 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| Octocrylene SCHEMBL1769135 | 0.93 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| SCHEMBL15492965 | 0.92 | ALDH1A1 (0.72) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| Octocrylene SCHEMBL28123035 | 0.92 | ALDH1A1 (0.98) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| Octocrylene SCHEMBL19583477 | 0.91 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPK1TDP1CYP3A4 | |
| Octocrylene SCHEMBL21835135 | 0.90 | ALDH1A1 (0.69) | ALDH1A1LMNAMAPK1TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | MARY KAY INC. (US) | 2026-03-26 | — | — | US | claimed |
| US-12453682-B2 | Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative | L'ORÉAL (FR) | 2025-10-28 | — | — | US | claimed |
| WO-2025072721-A1 | COMPOSITIONS | UVAGELESS LLC (US) | 2025-04-03 | — | — | WO | claimed |
| EP-4392144-A1 | SUNSCREEN COMPOSITION COMPRISING: A METAL OXIDE, SPF ACTIVE INGREDIENT; AND ONE OR MORE SPF ENHANCEMENT COMPONENT COMPRISING A PHOTOSTABILIZER, AN ANTIOXIDANT, OR A COMBINATION THEREOF | Colgate-Palmolive Company (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2024054923-A2 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | MARY KAY INC. (US) | 2024-03-14 | — | — | WO | claimed |
| US-20230404879-A1 | ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS | L'OREAL (FR) | 2023-12-21 | — | — | US | claimed |
| WO-2023224944-A1 | SUNSCREEN COMPOSITION COMPRISING: A METAL OXIDE, SPF ACTIVE INGREDIENT; AND ONE OR MORE SPF ENHANCEMENT COMPONENT COMPRISING A PHOTOSTABILIZER, AN ANTIOXIDANT, OR A COMBINATION THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2023-11-23 | — | — | WO | claimed |
| US-20230364005-A1 | Sunscreen Compositions and Methods of Use | COLGATE-PALMOLIVE COMPANY (US) | 2023-11-16 | — | — | US | claimed |
| WO-2022192882-A9 | TOPICAL COMPOSITIONS FOR UV PROTECTION | MARY KAY INC. (US) | 2023-03-23 | — | — | WO | claimed |
| US-20230044544-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2023-02-09 | — | — | US | claimed |
| EP-4076677-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2022-10-26 | — | — | EP | claimed |
| CN-114867715-A | Adhesive photoprotective compounds and uses thereof | 斯奇诺西维 | 2022-08-05 | — | — | CN | claimed |
| US-20220062126-A1 | UV SCREENING AND ANTIOXIDANT COMPOSITION AND USE THEREOF | BEIERSDORF AG (DE) | 2022-03-03 | — | — | US | claimed |
| WO-2022018376-A2 | ECOBIOLOGICAL FORMULATION, COMPATIBLE WITH CELL LIFE, USABLE IN THE COSMETIC, DERMOPHARMACEUTICAL OR VETERINARY FIELDS | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2022-01-27 | — | — | WO | claimed |
| US-20260115122-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | Galderma Holding SA (CH) | 2026-04-30 | — | — | US | disclosed |
| US-12605316-B2 | Alkenone-based formulations for topical applications | WOODS HOLE OCEANOGRAPHIC INSTITUTION (US) | 2026-04-21 | — | — | US | disclosed |
| US-20260096977-A1 | Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone | L'OREAL (FR) | 2026-04-09 | — | — | US | disclosed |
| WO-2011085298-A2 | COMPOSITIONS COMPRISING PIGMENT PARTICLES ENTRAPPED IN COLLAPSED POLYMERIC MICROSPHERES, AND METHODS OF MAKING THE SAME | ELC MANAGEMENT LLC (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2010129313-A2 | COSMETIC COMPOSITIONS COMPRISING CYANODIPHENYLACRYLATES | ELC MANAGEMENT LLC (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010129316-A2 | COSMETIC COMPOSITIONS COMPRISING CYANODIPHENYLACRYLATES AND FILM FORMING POLYMERS | ELC MANAGEMENT LLC (US) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096977-A1 | Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone | SOD1, TFEB, KLF5 | ALDH1A1 2714/4885LMNA 866/4885MAPK1 1803/4885 |
| US-20230044544-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | HAAO, HAO2, HPD | ALDH1A1 103/4885LMNA 1578/4885MAPK1 3298/4885 |
| US-12605316-B2 | Alkenone-based formulations for topical applications | CUTA, FLNA, TELO2 | ALDH1A1 986/4885LMNA 1103/4885MAPK1 3436/4885 |
| US-12453682-B2 | Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative | HAAO, HPD, P4HA1 | ALDH1A1 127/4885LMNA 1508/4885MAPK1 3213/4885 |
| US-20260115122-A1 | PERSONAL CARE COMPOSITIONS COMPRISING PANCRATIUM MARITIMUM | B3GNT2, GLA, AMPD2 | ALDH1A1 868/4885LMNA 2668/4885MAPK1 568/4885 |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | CUTA, TYR, SUN2 | ALDH1A1 327/4885LMNA 4254/4885MAPK1 4152/4885 |
| US-20230404879-A1 | ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS | TYR, TST, TSN | ALDH1A1 2063/4885LMNA 2326/4885MAPK1 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.